Novoron develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Our novel LRP-focused science enables hope for treatment of conditions for which no current therapies exist. We’re advancing multiple biological therapeutics that treat pathologies of the CNS, including multiple sclerosis, spinal cord injuries, and tauopathies such as Alzheimer’s.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $19.19M
Founded date: 2014
Founders name: Shawn Gahr
Investors 1
| Date | Name | Website |
| - | Phase Two ... | phasetwo.v... |
Funding Rounds 7
| Date | Series | Amount | Investors |
| 15.12.2022 | Seed | $9.5M | Two Bear C... |
| 15.09.2021 | Grant | $844.66K | National I... |
| 30.06.2021 | Seed | $3.5M | Two Bear C... |
| 15.09.2019 | Grant | $707.18K | National I... |
| 15.09.2018 | Grant | $695.05K | National I... |
| 15.09.2015 | Grant | $673.85K | National I... |
| 15.09.2014 | Grant | $264.55K | National I... |
Persons 12
| Date | First Name | Last Name | Title | Location | |||
| - | Matthew | Patterson | Research A... | linkedin.c... | - | m*********... | - |
| - | Shawn | Gahr | Co-founder... | linkedin.c... | - | s********r... | - |
| - | Travis | Stiles | President ... | linkedin.c... | - | t*********... | - |
| - | John | Stebbins | Director -... | linkedin.c... | - | j*********... | - |
| - | Tom | Gawriluk, ... | Spinal Cor... | linkedin.c... | - | t*********... | - |
| - | Ryan | Fischer | Laboratory... | linkedin.c... | - | r*********... | - |
| - | Namit | Singh | Senior Sci... | linkedin.c... | - | n*********... | - |
| - | Christina | Ly | Program Ma... | linkedin.c... | - | c*********... | - |
| - | Lucie | Oriol | Operations... | linkedin.c... | - | c*****t@no... | - |
| - | Michael | Kyweriga | Senior Sci... | linkedin.c... | - | m*********... | - |
Show more
Mentions in press and media 5
| Date | Title | Description |
| 17.11.2021 | Novoron Bioscience Raises $3M in Seed Financing from Two Bear Capital | SAN DIEGO, Nov. 16, 2021 /PRNewswire/ -- Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, announced today that they secured a $3 million Seed inv... |
| 17.11.2021 | Novoron Biosciences Picks Up $3M | San Diego-based Novoron Biosciences, a biotech company that is developing therapies aimed at reversing central nervous system (CNS) damage due to spinal cord injuries, has raised $3M in a seed fudning round. The company came from Two Bear C... |
| 23.09.2020 | San Diego startups lose Quick Pitch event in 2020, but gain alternative | San Diego’s startup scene is losing a favorite annual event this year with Quick Pitch on hiatus until the pandemic eases, organizers say. But a new event with a fresh group of partners is rolling out in its wake. The John G. Watson Quick P... |
| 22.12.2015 | Much like Biogen, Novoron developing drug to restore myelin sheaths in multiple sclerosis | Multiple sclerosis worsens as the body’s nerve cells deconstruct. Novoron’s lead compound, NOVO-117, targets a molecule called RhoA that has been found to inhibit the body’s natural remyelination process using oligodendrocyte precursor cell... |
| - | Much like Biogen, Novoron developing drug to restore myelin sheaths in multiple sclerosis | A promising new approach to treating multiple sclerosis is remyelination: That is, replenishing the fatty sheath surrounding nerve cells that degenerate in this autoimmune disease. Biogen is testing a drug that can restore the myelin sheath... |